Chargement en cours...
Anti-Proliferative Effects of Compound A and Its Effect in Combination with Cisplatin in Cholangiocarcinoma Cells
BACKGROUND: Cholangiocarcinoma (CCA) is a fatal cancer with high resistance to anticancer drugs. The development of new drugs or compounds to be used alone or in combination with currently available chemotherapeutic agents to improve the treatment of CCA is needed. Compound A (CpdA), which is a smal...
Enregistré dans:
| Publié dans: | Asian Pac J Cancer Prev |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
West Asia Organization for Cancer Prevention
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7779449/ https://ncbi.nlm.nih.gov/pubmed/32986368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2020.21.9.2673 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|